CEO Steve King speaking 1-18-17 at Immunotherapy World
The share price goes up yesterday in anticipation of SK's presentation, and down today because the company does not even mention it. BP's do not have to keep a lid on PPHM with this kind of strategy. One must wonder why it is necessary to get information about Peregrine from an indirect source...if at all.